Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report

Alessandro Sciarra; Ana Maria Autran Gomez; Alessandro Gentilucci; Ulderico Parente; Stefano Salciccia; Vincenzo Gentile; Franco Di Silverio

doi:10.1016/j.eururo.2007.03.083

Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report

Eur Urol. 2007 Aug;52(2):597-9. doi: 10.1016/j.eururo.2007.03.083. Epub 2007 Apr 4.

Authors

Alessandro Sciarra¹, Ana Maria Autran Gomez, Alessandro Gentilucci, Ulderico Parente, Stefano Salciccia, Vincenzo Gentile, Franco Di Silverio

Affiliation

¹ Department of Urology, University of Rome, Italy. sciarrajr@hotmail.com

PMID: 17420088
DOI: 10.1016/j.eururo.2007.03.083

Abstract

A 69-yr-old man with bilateral and metastatic renal cell carcinoma developed progressive disease after interleukin-2 and interferon therapy. He was submitted to radical left nephrectomy, right nephron-sparing surgery, and bone metastasis removal, followed by therapy with sorafenib. At 12-mo follow-up there was a significant improvement in patient performance status and no evidence of clinical progression.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / therapeutic use*
Benzenesulfonates / therapeutic use*
Bone Neoplasms / drug therapy*
Bone Neoplasms / secondary*
Bone Neoplasms / surgery
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / secondary*
Carcinoma, Renal Cell / surgery
Combined Modality Therapy
Humans
Kidney Neoplasms / pathology*
Kidney Neoplasms / surgery
Male
Niacinamide / analogs & derivatives
Phenylurea Compounds
Pyridines / therapeutic use*
Sorafenib

Substances

Antineoplastic Agents
Benzenesulfonates
Phenylurea Compounds
Pyridines
Niacinamide
Sorafenib